主持项目 (中国,自2019年起):
1. 国家自然科学基金面上项目,BRCA1-GATA3轴抑制基底样型乳腺癌发生的机制研究, 项目批准号: 81972637, 51万元, 2020年01月至 2023年 12月.
2.国家自然科学基金面上项目,GATA3缺失和R367X截短突变促进不同类型乳腺癌发生发展的机制研究, 项目批准号: 82372635, 49万元, 2024年01月至 2027年 12月.
3. 广东省自然科学基金项目-面上项目, 乳腺癌细胞增殖和分化的机制研究, 项目编号:2019A1515011343。10万元, 2019年10月 -- 2022年09月.
4.广东省自然科学基金项目-面上项目,GATA3功能缺失促进乳腺癌细胞去分化的机制研究. 项目批准号: 2024A1515013103, 15万,2024年01月至 2026年 12月.
5.深圳市自然科学基金项目-面上项目, 雌激素促进雌激素受体阴性乳腺癌转移的机制研究。项目编号:JCYJ20190808115603580 。40万元, 2020年05月至 2023年 5月.
6.深圳市自然科学基金项目-面上项目, BRCA1缺失激活PDGFRβ信号通路增加乳腺癌转起始细胞的机制研究。项目编号:JCYJ20210324094611032 。60万元, 2021年10月至 2024年 10月.
主持项目 (美国,截止2018年,共13项271万美元,下列代表性三项):
1. BRCA1 controls mammary stem/progenitor differentiation and proliferation, epithelial-mesenchymal transition and tumorigenesis
PI: Pei XH (裴新海)
Agency: Congressionally Directed Medical Research Programs--Breast Cancer Research Program 美国国会指导医学研究项目--乳腺癌研究奖
Type: Idea Award (W81XWH-10-1-0302)
Amount: $554,491
Period: 4/15/2010 – 5/14/2012
2. The Role of BRCA1 in Suppressing Epithelial-Mesenchymal Transition in Mammary Gland and Tumor Development
PI: Pei XH (裴新海)
Agency: Congressionally Directed Medical Research Programs--Breast Cancer Research Program 美国国会指导医学研究项目--乳腺癌研究奖
Type: Idea Expansion Award (W81XWH1310282)
Amount: $537,779
Period:9/1/2013 – 8/31/2016
3. Targeting BRCA1 deficient breast cancers
PI: Pei XH (裴新海)
Agency:Florida Department of Health 美国佛罗里达州卫生部
Type: Bankhead Coley Cancer Research Grant Award肿瘤研究奖(7BC07)
Amount: $97,880
Period: 3/1/17 - 2/28/18
代表性成果:
1. Wang X, Bai F, Liu X, Peng B, Xu X, Zhang H, Fu L, Zhu WG, Wang B*, Pei XH*. GATA3 functions downstream of BRCA1 to promote DNA damage repair and suppress dedifferentiation in breast cancer. BMC Biology. 2024, Apr 16;22(1):85.
2. Ren S, Bai F, Schnell V, Stanko C, Ritsch M, Schenk T, Barth E, Marz M, Wang B, Pei XH* and Bierhoff H*. PAPAS promotes differentiation of mammary epithelial cells and suppresses breast carcinogenesis. Cell Reports. 2024, Jan 23;43(1):113644.
3. Liu X, Bai F*, Wang Y, Wang C, Chan HL, Zheng C, Fang J, Zhu WG, and Pei XH*. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis. Cell Death & Disease. 2023, Jun 23;14(6):370.
4. Bai F, Wang C, Liu X, Hollern D, Liu S, Fan C, Liu C, Ren, S, Herschkowitz JI, Zhu WG, Pei XH*. Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway. Cell Death & Disease. 2022, Mar 2, 13(3):195.
5. Bai F#, Zheng C#, Liu X, Chan HL, Liu S, Ma J, Ren, S, Zhu WG, Pei XH*. Loss of function of GATA3 induces basal-like mammary tumors. Theranostics. 2022, Jan 1, 12(2):720-733.
6. Bai F, Zhang L, Liu X, Wang C, Zheng C, Sun J, Li M, Zhu WG, Pei XH*. GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer. Theranostics. 2021, Jul 13, 11(17):8218-8233.
7. Bai F, Liu S, Liu X, Hollern DP, Scott A, Wang C, Zhang L, Fan C, Fu L, Perou CM, Zhu WG, Pei XH*. PDGFRβ is an essential therapeutic target for BRCA1 deficient mammary tumors. Breast Cancer Research. 2021, Jan 21, 23(1):10:1-17.
9. Wang C, Bai F*, Zhang L, Scott A, Li E*, Pei XH*. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression. Breast Cancer Research. 2018, Jul 11, 20:74:1-17.
10. Bai F#, Chan HL#, Scott A, Smith MD, Fan C, Herschkowitz JI, Perou, CM, Livingstone AS, Robbins DJ, Capobianco AJ, Pei XH*. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. Cancer Research. 2014, 74(21):6161-6172.
11. Bai F, Smith MD, Chan HL, Pei XH*. Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation. Oncogene. 2013, 30;32(22): 2715-2725. Featured Article.
12. Pei XH, Bai F, Li Z, Smith MD, Whitewolf G, Jin R, and Xiong Y*. Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis. Cancer Research. 2011, 71:2969-2977.
13. Pei XH#, Bai F#, Smith MD, Usary J, Fan C, Pai SY, Ho IC, Perou CM, Xiong Y*. CDK inhibitor p18INK4c is a downstream target of GATA3 and controls mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell, 2009;15: 389-401.
用户登录
还没有账号?
立即注册